UnicoCell Biomed Co., Ltd. (TPE:6794)
Taiwan · Delayed Price · Currency is TWD 87.00
+0.10 (0.12%)
Feb 11, 2026, 1:30 PM CST
UnicoCell Biomed Market Cap
UnicoCell Biomed has a market cap or net worth of 5.27 billion as of February 10, 2026. Its market cap has increased by 29.15% in one year.
Market Cap
5.27B
Enterprise Value
4.74B
Revenue
34.58M
Ranking
n/a
PE Ratio
n/a
Stock Price
87.00
Market Cap Chart
Since December 25, 2020, UnicoCell Biomed's market cap has increased from 1.73B to 5.27B, an increase of 205.16%. That is a compound annual growth rate of 24.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 10, 2026 | 5.27B | -3.01% |
| Dec 31, 2025 | 5.44B | 36.28% |
| Dec 31, 2024 | 3.99B | -13.33% |
| Dec 29, 2023 | 4.60B | 239.58% |
| Dec 30, 2022 | 1.36B | -17.13% |
| Dec 30, 2021 | 1.64B | 1.26% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 25, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Savior Lifetec | 5.96B |
| OBI Pharma | 5.93B |
| Sinphar Pharmaceutical | 5.83B |
| CHO Pharma | 5.66B |
| Pharmosa Biopharm | 5.45B |
| Locus Cell | 5.40B |
| Panion & Bf Biotech | 5.34B |
| Steminent Biotherapeutics | 5.06B |